<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<description>PR-inside.com Free Press Releases Services</description>
	<title>PR-inside.com News</title>
	<link>http://www.pr-inside.com/</link>
    <copyright>Copyright 12</copyright>
    <generator>pr-inside.com</generator>
    <category>health</category>
	<item>
	<category>Health</category>
	<title>Market Report, "ONTEX International N.V. - Strategic SWOT Analysis Review", published</title>
	<description>
	
(PR-inside.com) ONTEX International N.V. (ONTEX) is a healthcare company engaged in the design, development, manufacture and marketing of private label hygienic disposables. The company's product line includes feminine care products, baby care products and adult care products. Ontex divided its operations into three divisions, namely, Retail division. Healthcare division and Turkey regional division. Its products are manufactured in 12 manufacturing plants it operates throughout the world. ONTEX supplies its incontinence and medical products to hospitals, nursing homes and home care environments. The company's products are sold through a wide network of subsidiaries across Belgium, Spain, Germany, France, Italy, the UK, China, ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:33:46 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-ontex-international-n-v-r3051738.htm</guid>
	<link>http://reports.pr-inside.com/market-report-ontex-international-n-v-r3051738.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>"Goold Health Systems, Inc. - Strategic SWOT Analysis Review" now available at Fast Market Research</title>
	<description>
	
(PR-inside.com) Goold Health Systems, Inc. (GHS) is a privately-held healthcare management company that focuses on providing pharmacy benefit services, clinical services and business process outsourcing services. The company divided its operations into three divisions, namely, Pharmacy services, Clinical services, and Business Process Outsourcing. GHS offers services to State Medicaid agencies, non-profit clients and private sector clients. It provides various levels of pharmacy and related services to ten State Medicaid Agencies. The company collaborates with clients throughout the US to enhance healthcare systems. GHS is affiliated to the Waldron Group of Companies. It has satellite offices in Iowa, Wyoming, Cheyenne, Des Moines, ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:30:23 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/goold-health-systems-inc-strategic-r3051730.htm</guid>
	<link>http://reports.pr-inside.com/goold-health-systems-inc-strategic-r3051730.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>"First Health Services Corporation - Strategic SWOT Analysis Review" Published</title>
	<description>
	
(PR-inside.com) First Health Services Corporation (First Health Services) is a leading provider of integrated clinical management services for public sector healthcare clients. The company is engaged in providing healthcare management and administrative services for public sector health benefit programs across the US. Some of the major offerings of the company include Health Care Management Services, Fiscal Agent Services and Pharmaceutical Services. In addition, the company supports administrative functions of Medicaid program including claims adjudication, provider network development and management, benefits administration, provider payment and financial services. First Health Services is headquartered Glen Allen (Virginia), the US.


Full Report Details at
 - http://www.fastmr.com/prod/244884_first_health_services_corporation_strategic_swot.aspx


As ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:29:18 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/first-health-services-corporation-r3051727.htm</guid>
	<link>http://reports.pr-inside.com/first-health-services-corporation-r3051727.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Recently released market study: BIOTRONIK SE &amp; Co. KG - Strategic SWOT Analysis Review</title>
	<description>
	
(PR-inside.com) BIOTRONIK SE &amp; Co. KG (BIOTRONIK) is a biomedical company engaged in the development, manufacture and marketing of medical devices, with principal focus on two business areas, namely, Vascular Intervention and Electrotherapy of the heart. Its devices assist physicians in enhancing the patient's quality of life. Its Electrotherapy offers diagnostic tools and options for treating arrhythmias. The company's Vascular Intervention provides solutions for stenosis and occlusion of arterial vessels. BIOTRONIK has presence in Europe, North America, Latin America, Asia, Oceania and Africa. Its products are sold in more than 100 countries around the world. BIOTRONIK is headquartered in Berlin, Germany.

BIOTRONIK ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:27:20 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/recently-released-market-study-biotronik-r3051720.htm</guid>
	<link>http://reports.pr-inside.com/recently-released-market-study-biotronik-r3051720.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Study Published: Venezuela Pharmaceuticals &amp; Healthcare Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: While Venezuela's increasingly harsh pricing regime looks unlikely to address persistent medicine shortages, President Hugo Chavez's renewed attempts to regulate the country's pharmaceutical sector confirm our long-standing view that Venezuela's fiscal - and to a larger extent political - trajectory present a considerable roadblock for drugmakers looking to make new investment.

Headline Expenditure Projections

 * Pharmaceuticals: VEF26.70bn (US$6.21bn) in 2010 to VEF33.25bn (US$5.45bn) in 2011; +24.6% in local currency terms and -12.2% in US dollar terms. US forecast down due to new macro data.
 * Healthcare: VEF53.20bn (US$12.37bn) in 2010 to VEF65.37bn (US$10.72bn) in 2011; +22.9% in local currency ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:24:46 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-study-published-venezuela-pharmaceutica-r3051711.htm</guid>
	<link>http://reports.pr-inside.com/new-market-study-published-venezuela-pharmaceutica-r3051711.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>"United Kingdom Pharmaceuticals &amp; Healthcare Report Q1 2012" now available at Fast Market Research</title>
	<description>
	
(PR-inside.com) BMI View: Highlighting the government's recognition of the importance of creating an attractive business environment for drugmakers, in early December 2011, the Prime Minister announced a series of measures to boost the healthcare and life sciences sectors, reflecting an intention to maintain a strong presence in the global pharmaceutical industry. BMI believes the measures will encourage R&amp;D in the UK's pharmaceutical industry and will contribute towards maintaining jobs in the sector. While the local pharmaceutical industry does not employ a large proportion of the UK labour force, the closure of sites by multinational drugmakers during the economic slowdown will put ..
	</description>
	
	<pubDate>Thu, 16 Feb 2012 01:18:24 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/united-kingdom-pharmaceuticals-r3051695.htm</guid>
	<link>http://reports.pr-inside.com/united-kingdom-pharmaceuticals-r3051695.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>I Don't Know How She Does It Features Lice Busters Lice Removal Service</title>
	<description>
	
(PR-inside.com) Lice Busters, a veteran force in the lice removal industry known for its all-natural products, is promoting its recent Hollywood debut as the go-to lice service in "I Don't Know How She Does It," a 2011 film staring Sarah Jessica Parker. Available online at http://www.LiceBusters.co, the head lice treatment company has been prominently featured in The New York Times, The Wall Street Journal, NPR, and CBS, among other top outlets, and is also a top choice among celebrities, private schools, and other clients requiring discretion. 

"We were extremely excited to be featured in 'I Don't Know How She Does It,' ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 17:50:21 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/i-don-t-know-how-she-does-r3051340.htm</guid>
	<link>http://www.pr-inside.com/i-don-t-know-how-she-does-r3051340.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Which State Loves Pets more Naturally?</title>
	<description>
	
(PR-inside.com) Ferndale, WA (USA), Tuesday - February 14, 2012 -- 

According to AllPetNaturals ( http://www.allpetnaturals.com ), an online webstore that offers natural pet care supplies, organic treats, herbal remedies and eco friendly companion animal accessories, California headed the annual list of the 10 most naturally-minded U.S. states. Pennsylvania is the runner-up. Followed by North Carolina, New Jersey and Nevada.

AllPetNaturals ( http://www.allpetnaturals.com ) creates its list by comparing sales data of natural pet product such as herbal remedies, homeopathics, organic treats, catnip, books, music for pets and eco friendly pet furniture and adventure clothing for dogs.

Quality Remedies Inspired by Nature http://www.allptetnaturals.com

About All ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 16:34:19 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/which-state-loves-pets-more-naturally-r3051192.htm</guid>
	<link>http://www.pr-inside.com/which-state-loves-pets-more-naturally-r3051192.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Greenville EyeCare’s Meghan Barker Earns Opticianry Certification</title>
	<description>
	
(PR-inside.com) Greenville, SC - - February 15, 2012 - - Greenville EyeCare Associates, a provider of comprehensive eye healthcare services, proudly announces that Meghan Barker recently earned the American Board of Opticianry (ABO) certification. The ABO is the largest and most prestigious opticians’ certification organization in the world that only recognizes individuals whose opticianry skills and knowledge meet pre-determined standards of excellence. Meghan successfully met all program requirements and demonstrated competency in ophthalmic dispensing as part of the skills assessment test and exams administered by the ABO. Exams cover areas for analyzing and interpreting prescriptions; identifying proper lenses and frames required ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 16:28:50 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/greenville-eyecare-s-meghan-barker-earns-r3051172.htm</guid>
	<link>http://www.pr-inside.com/greenville-eyecare-s-meghan-barker-earns-r3051172.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Market Report, "South Africa Pharmaceuticals &amp; Healthcare Report Q1 2012", published</title>
	<description>
	
(PR-inside.com) BMI View: South Africa's timescale for enacting its National Health Insurance (NHI) scheme is practical and achievable, as are the country's plans to improve governance, administration and funding. However, less welcome is the government's anti-commercial rhetoric and habit of politicising healthcare along racial lines. This will worry private healthcare providers as the government's plans to ease non-public healthcare prices - to move people off the state system and onto more affordable private care - could involve blanket price control measures that negatively impact the profitability of these businesses. Nevertheless, the NHI also presents huge opportunities for private health insurance providers ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 13:42:07 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-south-africa-pharmaceuticals-r3050748.htm</guid>
	<link>http://reports.pr-inside.com/market-report-south-africa-pharmaceuticals-r3050748.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Report: Northstar Neuroscience, Inc. (NSTR) - Strategic SWOT Analysis Review</title>
	<description>
	
(PR-inside.com) Northstar Neuroscience, Inc. (Northstar) is principally engaged in the manufacture and development of novel neurostimulation therapies for a broad range of neurological diseases and disorders. The product developed by the company includes the Renova Cortical Stimulation Systems. This System consists of the various components like Implantable pulse generator, cortical stimulation lead and the Programming system. Northstar Neuroscience principally operates in United States. It is headquartered in Seattle, US.

In January 2009, the company's board of directors approved the plan of liquidation and dissolution of the company. Also in November 2008, the company received FDA approval to conduct clinical study for its ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 13:33:24 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-report-northstar-neuroscience-inc-r3050699.htm</guid>
	<link>http://reports.pr-inside.com/new-market-report-northstar-neuroscience-inc-r3050699.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Report: LifeMasters Supported SelfCare, Inc. - Strategic SWOT Analysis Review</title>
	<description>
	
(PR-inside.com) LifeMasters Supported SelfCare, Inc. (LifeMasters) is a US based disease management company. The company is engaged in the provision of a wide range of health improvement programs and services to insurers, employers, hospitals and physicians. LifeMasters offers programs for individuals with congestive heart failure, chronic obstructive pulmonary disease, diabetes, coronary artery disease, hypertension, musculoskeletal pain, and asthma. The company caters to both the public and the private sector.The company is accredited by the National Committee for Quality Assurance (NCQA) and Utilization Review Accreditation Commission (URAC). Through a network of offices in California, Indiana, Texas, and New Mexico, the company conducts ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 13:33:01 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-report-lifemasters-supported-selfcare-r3050696.htm</guid>
	<link>http://reports.pr-inside.com/new-market-report-lifemasters-supported-selfcare-r3050696.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>ERT Launches New Website to Support Significant Commercial Growth</title>
	<description>
	
(PR-inside.com) PHILADELPHIA, PA, 15 February - ERT, a global technology-driven provider of health outcomes services and customizable medical devices to biopharmaceutical sponsors and Contract Research Organizations (CROs), announced today the launch of a new corporate website to further elevate its market and thought leadership position. Complementing the company’s commercial growth in the last 18 months, web traffic to ERT’s website increased by 41% from June 2010 to October 2011, as visitors sought further detailed information about ERT’s comprehensive range of Cardiac Safety, Respiratory and ePRO solutions. To access the new website, visit www.ert.com.

The newly created website has been designed to reflect ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 13:26:10 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/ert-launches-new-website-to-support-r3050680.htm</guid>
	<link>http://www.pr-inside.com/ert-launches-new-website-to-support-r3050680.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Chapel Hill Tubal Reversal Center Surgeons Published in Leading Medical Journal</title>
	<description>
	
(PR-inside.com) Dr. Charles Monteith and Dr. Gary Berger of Chapel Hill Tubal Reversal Center are the authors of "Successful pregnancies after removal of intratubal microinserts" published in the February 2012 edition of Obstetrics and Gynecology pages 470-472. This is the first medical article of this kind and adds to medical history. Having experienced very successful reversal of intratubal microinsert stertilization, patients have become pregnant and given birth to healthy babies.

Women who have the intratubal microinserts (Essure Sterilization) may regret their decision. In many cases when the patients have contacted the physician who performed the sterilization procedure with question of reversal the ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 13:14:05 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/chapel-hill-tubal-reversal-center-surgeons-r3050661.htm</guid>
	<link>http://www.pr-inside.com/chapel-hill-tubal-reversal-center-surgeons-r3050661.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Eyewear professionals claim eyeglass slipping is just bad fit - not true</title>
	<description>
	
(PR-inside.com) "Slippery things like to slip, it's in their nature. That's why I find it really really funny when the eyeglass industry says things like 'eyeglasses would not slip if they were fit properly.' But no, that's not true, more importantly it's not logical." says Michael Wong, marketing manager for the Keepons brand of eyewear retainers.

Wong is trying to educate the public, namely the hundreds of millions of eyeglass wearers around the world who suffer from eyeglass slipping on a daily basis. He admits to understanding why it's done though, why eyewear professionals have to stick to their guns about ill-fitting ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 08:42:39 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/eyewear-professionals-claim-eyeglass-slipping-r3050070.htm</guid>
	<link>http://www.pr-inside.com/eyewear-professionals-claim-eyeglass-slipping-r3050070.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Octapharma AG - Strategy and SWOT Report</title>
	<description>
	
(PR-inside.com) Octapharma AG - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360deg view of the company.

Features:

 * Detailed information on Octapharma AG required for business and competitor intelligence needs
 * A study of the major internal and external factors affecting Octapharma AG in the form of a SWOT analysis
 * An in-depth view of the business model of Octapharma AG including a breakdown and examination of key business segments
 * Intelligence on Octapharma AG's mergers and acquisitions ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 08:43:39 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-octapharma-ag-r3050057.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-octapharma-ag-r3050057.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Whole Body Vibration Machine</title>
	<description>
	
(PR-inside.com)  People are more conscious about their look and style, they need perfect body with attractive looks. They need to maintain proper body weight for the active and healthy lifestyle.

Healthy body not only keeps an individual fit but also helps them to remain free from certain health diseases. Sometimes it becomes difficult for an individual to go to gym for the regular workout due to their busy schedule. Due to the busy schedule and high membership fees, some can't afford going gym . There are broad variety of home fitness equipment available in the market from which one can choose ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 06:18:10 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/whole-body-vibration-machine-r3049893.htm</guid>
	<link>http://www.pr-inside.com/whole-body-vibration-machine-r3049893.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Now Available: URSA Major Minerals Incorporated (UMJ) - Financial and Strategic SWOT Analysis Review</title>
	<description>
	
(PR-inside.com) URSA Major Minerals Incorporated is a mineral exploration and development company, based in Canada. It is into the development of nickel, copper and precious metal deposits. The company is engaged in certain projects which are located in Shakespeare, Porter, Baldwin and Hyman townships. The Porter Baldwin property covers a 37,000 acre exploration property. The Shakespeare Project has a substantial mineral reserve which produced 4500 tone/day. The company also holds 100% interest in the Shining Tree nickel-copper deposit, Sudbury. The company has a strategic alliance with Korea Resources Corporation to identify and acquire significant advanced base metal exploration projects for exploration ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 05:50:55 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/now-available-ursa-major-minerals-incorporated-r3049826.htm</guid>
	<link>http://reports.pr-inside.com/now-available-ursa-major-minerals-incorporated-r3049826.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Report Now Available: Medicalis Corporation - Strategic SWOT Analysis Review</title>
	<description>
	
(PR-inside.com) Medicalis Corporation (Medicalis) is principally engaged in the development of radiology workflow and decision support solutions. The company offers solutions for hospitals and EMRs, which include Decision Support Server and Medicalis Analytics. The solutions also validate clinical orders and promote cost-effective quality in diagnostic healthcare. The company' s collaborative workflow solutions enhance productivity and optimize utilization using evidence based knowledge to improve the quality. Its range of customers includes imaging centers, hospitals, professional radiology groups, in the United States and Canada for their patients. Medicalis is headquartered in San Francisco, California, the US.

Medicalis Corporation Key Recent Developments


Full Report Details at
 ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:38:02 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-report-now-available-medicalis-r3049617.htm</guid>
	<link>http://reports.pr-inside.com/new-market-report-now-available-medicalis-r3049617.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Just Released: "HeartSine Technologies, Inc. - Strategic SWOT Analysis Review"</title>
	<description>
	
(PR-inside.com) HeartSine Technologies, Inc. (HeartSine) is a medical device company, which is principally engaged in the development of easy-to-use defibrillators for the home and public access markets. The company's core technologies include cardiac defibrillation, pacing and cardioversion, SCOPE biphasic waveform technology, arrhythmia detection, diagnostic algorithms, innovative sensor technology and defibrillator electrode technologies. Its flagship product SAMARITAN public access defibrillator (PAD) is an easy-to-use medical device especially designed for public access use, to administer lifesaving treatment for sudden cardiac arrest. This product can now be combined with recently introduced pediatric-Pak to use on pediatric patients. Its operations are concentrated in Ireland and ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:33:50 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/just-released-heartsine-technologies-inc-r3049609.htm</guid>
	<link>http://reports.pr-inside.com/just-released-heartsine-technologies-inc-r3049609.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Report Now Available: Vietnam Pharmaceuticals &amp; Healthcare Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: Despite strong growth potential, the government's protectionist policy of preventing foreignowned companies from distributing their products and other regulatory inefficiencies will continue to hinder the development of the pharmaceutical sector in the country. We note that the country will continue to rely heavily on pharmaceutical imports given that counterfeits drugs are rampant and that the domestic pharmaceutical sector is still underdeveloped. As the country joins other Asian countries such as Singapore, Taiwan, South Korea and Malaysia in their quest to use biotechnology to boost the economy, we believe that the country will continue to underperform in this area ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:29:52 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-report-now-available-vietnam-r3049595.htm</guid>
	<link>http://reports.pr-inside.com/new-market-report-now-available-vietnam-r3049595.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Thailand Shipping Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: Floods and World Economy Weigh on Forecasts

Since our last quarterly report, prospects for Thailand's ports and shipping sector have taken a knock, with the country suffering the worst flooding in half a century and Bangkok's urban area particularly affected. Estimates of the costs of flood damage range at 3% of GDP or higher. Manufacturing and export industries were disrupted in the last quarter of 2011, and some of this will spill over into early 2012. While BMI believes infrastructure reconstruction efforts and government spending in the first half of 2012 will stimulate activity, against this we note that ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:28:50 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-thailand-shipping-r3049591.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-thailand-shipping-r3049591.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Sri Lanka Pharmaceuticals and Healthcare Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: Sri Lanka's pharmaceutical market is expected to post a 2010-2015 compound annual growth rate (CAGR) of 10.2%, as measured in local currency terms. Nevertheless, by 2015, the market will still be worth less than US$700mn, on account of low pharmaceutical prices and low per capital spending on medicines. Additionally, government proposals to establish pharmaceutical price controls have unsurprisingly been met with opposition from the pharmaceutical industry. In the meantime, the business climate is in need of improvement, due to widespread corruption and red tape.


Full Report Details at
 - http://www.fastmr.com/prod/329523_sri_lanka_pharmaceuticals_and_healthcare_report.aspx


Headline Expenditure Projections

 * Pharmaceuticals: LKR43.62bn (US$386mn) in 2010 to ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:27:08 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-sri-lanka-r3049587.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-sri-lanka-r3049587.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Study Published: Iraq Pharmaceuticals &amp; Healthcare Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: Iraq is gradually recovering following the invasion, which is providing commercial draws to potential investors. However, challenges - political, social and demographic - will continue to deter smaller, risk-adverse companies. Pharmaceutical spending will remain modest by global standards, although the government appears to be committed to improving access to necessary medicines and the restoration of healthcare provision, backed by oil revenues.

Headline Expenditure Projections

 * Pharmaceuticals: IQD813.34bn (US$696mn) in 2010 to IQD1,017bn (US$870mn) in 2011; +25.1% in local currency and +25.0% in US dollar terms. Local forecast up slightly from Q411 due to currency factors.
 * Healthcare: IQD4,240bn (US$3.63bn) ..
	</description>
	
	<pubDate>Wed, 15 Feb 2012 02:25:50 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-study-published-iraq-pharmaceuticals-r3049584.htm</guid>
	<link>http://reports.pr-inside.com/new-market-study-published-iraq-pharmaceuticals-r3049584.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>How Rite-Aid, Highmark, Kaiser Permanente Use Pharmacists to Improve Medication Adherence</title>
	<description>
	
(PR-inside.com) SEA GIRT, NJ, USA, February 10, 2012 --- Pharmacist-based interventions that take place in pharmacies, in patient-centered medical homes or virtually are helping to improve levels of medication adherence in patients and health plan members. "Pharmacists and Medication Adherence: Brief Interventions, Motivational Interviewing and Telepharmacy," a new resource from the Healthcare Intelligence Network, profiles some innovative medication adherence models built around pharmacists. 

CMS Innovation Advisor Janice Pringle, Ph.D., of the University of Pittsburgh School of Pharmacy, is among the contributors to this newly published 50-page report. 

See table of contents for "Pharmacists and Medication Adherence" at: http://www.hin.com/cgi-local/link/news/pl.cgi?pharmpr. 

NEWS FACTS: 

Pharmacists ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 21:55:54 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/how-rite-aid-highmark-kaiser-permanente-use-r3049536.htm</guid>
	<link>http://www.pr-inside.com/how-rite-aid-highmark-kaiser-permanente-use-r3049536.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>FDA Bans Sales of HCG-Placenta-Based Weight Loss Remedy</title>
	<description>
	
(PR-inside.com) In early December, Federal regulators ordered several companies to stop selling an unproven weight loss remedy that uses protein from the human placenta.

The FDA issued warning letters to seven companies that sell the protein as drops, pellets or sprays. Human chorionic gonadotropin (HCG) is produced by the placenta and found in the urine of pregnant women. While it is approved for certain infertility treatments, the FDA says there is no evidence it helps reduce weight.

“There is no evidence that HCG has any beneficial effect on weight loss, and it’s potentially harmful,” say boomer generation health experts Dian Griesel, Ph.D., and ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 16:10:02 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/fda-bans-sales-of-hcg-placenta-based-weight-r3049095.htm</guid>
	<link>http://www.pr-inside.com/fda-bans-sales-of-hcg-placenta-based-weight-r3049095.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>High-Throughput&amp;High-Salt Measurements of Electrophoretic Mobility(Zeta Potential)with Wyatt Technology’s Möbius</title>
	<description>
	
(PR-inside.com) (SANTA BARBARA, CALIFORNIA – February 14 2012) Wyatt Technology Corporation, the world leader in absolute macromolecular characterization instrumentation and software, today announces that it will be showcasing its innovative zeta potential instrument, the Möbius™, at PITTCON 2012. The Möbius has been developed to automate the measurement of the mobility and the hydrodynamic radius of precious protein samples, increasing throughput without modifying the species. Additionally, the instrument is designed to facilitate analyses in high-saline conditions, expanding the capability of the laboratory. Wyatt Technology will exhibit the Möbius on booth #2281 at PITTCON 2012, Orlando, FL, March 11- March 15, 2012.

Previously, conventional ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 16:03:56 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/high-throughput-high-salt-measurements-of-r3049034.htm</guid>
	<link>http://www.pr-inside.com/high-throughput-high-salt-measurements-of-r3049034.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>DNA Electronics CEO Professor Chris Toumazou To Address Scripps “Future of Genomic Medicine” Conference</title>
	<description>
	
(PR-inside.com) London, United Kingdom, February 14th 2012 – DNA Electronics Ltd. a developer of semiconductor solutions for real-time DNA and RNA detection, today announces that DNA Electronics Chairman and CEO Professor Chris Toumazou FRS will be an invited speaker at the upcoming “The Future of Genomic Medicine V” conference presented by the Scripps Translational Science Institute (March 1-2 2012, La Jolla, California). 

Professor Toumazou will be speaking as part of the “Hot Topics in Genomic Medicine” track, addressing a key presentation on “DNA Transistors and Handheld Sequencing” to the conference audience of physicians, healthcare professionals, human geneticists, genomic scientists and researchers. ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 12:54:58 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/dna-electronics-ceo-professor-chris-toumazou-r3048607.htm</guid>
	<link>http://www.pr-inside.com/dna-electronics-ceo-professor-chris-toumazou-r3048607.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Intelligent InSites Leverages Trimble’s ThingMagic RFID Technology</title>
	<description>
	
(PR-inside.com) Fargo, ND, February 14, 2012 -- Intelligent InSites, Inc., the leading provider of enterprise real-time location systems (RTLS) software helping hospitals improve patient satisfaction and operational performance while supporting multiple radio frequency identification (RFID) and RTLS technologies, has announced that its InSites RTLS solution supports ThingMagic Astra® readers for passive RFID data integration.

“The ability of the InSites solution to automatically collect and intelligently process real-time location data from a variety of locating technologies is unique in the RTLS space said Ralf Mehnert-Meland, Director of Developer/OEM Relationships at Intelligent InSites. “We continue to expand our enterprise software by adding support for ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 12:44:19 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/intelligent-insites-leverages-trimble-s-thingmagic-r3048526.htm</guid>
	<link>http://www.pr-inside.com/intelligent-insites-leverages-trimble-s-thingmagic-r3048526.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Author releases Sensitive and Insightful book on Child Bereavement and Therapy - A Grief Unobserved</title>
	<description>
	
(PR-inside.com) There is a wonderful book by C S Lewis in which he describes the process of coming to terms with his bereavement - the 'grief observed' which most adults will experience at some time in their lives… this book is about the grief not observed, that of very young children.
It is for parents, carers, and professionals who work with them: there are many books about child development, bereavement, and therapy, but not many about loss of a parent where a young child is involved. Very often the remaining parent, close relatives and well-meaning friends, are understandably so involved with their ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 08:10:48 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/author-releases-sensitive-and-insightful-book-r3048017.htm</guid>
	<link>http://www.pr-inside.com/author-releases-sensitive-and-insightful-book-r3048017.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Pacific Carpet &amp; Tile Cleaning Up San Diego with Healthy Steam Clean Carpet Programs</title>
	<description>
	
(PR-inside.com) In San Diego County, health practitioners agree it is of vital importance that carpet steam cleaning is performed on a regular basis due all the harmful soils and allergens that are in the air. These soils and allergens carry dangerous bacteria that can make you and your family sick. These allergens and bacteria settle on your carpet, tile and upholstery. They then fester, multiply and grow causing sickness and in some cases even death!

There is a debate going on between consumers and carpet cleaners over which method of carpet cleaning is most effective in removing harmful allergens and bacteria. 

Dry ..
	</description>
	
	<pubDate>Tue, 14 Feb 2012 01:23:04 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/pacific-carpet-tile-cleaning-up-r3047828.htm</guid>
	<link>http://www.pr-inside.com/pacific-carpet-tile-cleaning-up-r3047828.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Atlanta-area Manufacturer of Medical Compression Stockings, SIGVARIS, 
Teams Up with Local Boy Scouts</title>
	<description>
	
(PR-inside.com) PEACHTREE CITY, GA – Last year, the local Boy Scouts raised more than 20,000 food items for local organizations committed to helping people. This year, employees at SIGVARIS helped set the Boy Scouts up for an even bigger total in 2012 by helping them raise more than 7,000 items for the Real Life Center. 

The Real Life Center is a local organization committed to helping families get back on their feet financially, emotionally or spiritually during tough times. The Boy Scouts created the “Scouting for Food” program to help collect food for organizations like these that are committed to helping ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 21:06:24 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/atlanta-area-manufacturer-of-medical-compression-r3047604.htm</guid>
	<link>http://www.pr-inside.com/atlanta-area-manufacturer-of-medical-compression-r3047604.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Amnesty on Hearing Loss in London</title>
	<description>
	
(PR-inside.com) There will be an Amnesty on hearing abuse this week as national charity Deafness Research UK pops into the offices of international charity Amnesty International to conduct free hearing screening for staff.
 
Deafness Research UK is on a mission to get people to fall in love with their hearing, so it’s appropriate that the screenings will be available from 10.30 am on Valentine’s Day, Tuesday 14 February, when Deafness Research UK’s team of experts will be on hand with advice on hearing and hearing screening for those who would like it.
 
Together with the award winning Bionic Ear Show, dedicated ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 16:48:52 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/amnesty-on-hearing-loss-in-london-r3047306.htm</guid>
	<link>http://www.pr-inside.com/amnesty-on-hearing-loss-in-london-r3047306.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>PENTAX Launches the World’s First HD Video Bronchoscope</title>
	<description>
	
(PR-inside.com) PENTAX Life Care, experts in high definition endoscopy, has introduced the world’s first HD (high definition) video bronchoscope. The newest addition to PENTAX Life Care’s well established range of high definition HD+ endoscopes, the EB-1990i HD+ Bronchoscope sets a new standard for state-of-the-art bronchoscopy and provides incomparable image quality in pulmonology. 

The new EB-1990i HD+ Bronchoscope is the first high definition bronchoscope with a megapixel CCD that presents clear high resolution images with highly accurate, natural colour reproduction. This provides users with excellent image quality in combination with leading ergonomics for better orientation and detection. Incorporated with PENTAX’s industry leading ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 16:35:45 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/pentax-launches-the-world-s-first-hd-r3047300.htm</guid>
	<link>http://www.pr-inside.com/pentax-launches-the-world-s-first-hd-r3047300.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>March 14, 2012 Webinar: Best Practices for Recruiting and Training Results-Driven Case Managers</title>
	<description>
	
(PR-inside.com) SEA GIRT, NJ, USA, February 10, 2012 --- Recruiting sources, skill sets, education schedule --- all part of Agate Healthcare's winning game plan for hiring and training healthcare case managers that positively impact population health outcomes and the bottom line that will be presented during the March 14, 2012 webinar, "Recruiting and Training for Results-Driven Case Management." 

The 45-minute webinar, scheduled for 1:30 p.m. Eastern time, is sponsored by the Healthcare Intelligence Network. 

Learn how to recruit and train results-oriented healthcare case managers at: http://www.hin.com/cgi-local/link/news/pl.cgi?rtcmpr. 

NEWS FACTS: 

* Scheduled Speaker: Mary Anderson, RN, CPHQ, IQCI, CPHM, CPUR, interim director of ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 16:15:56 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/march-14-2012-webinar-best-practices-r3047284.htm</guid>
	<link>http://www.pr-inside.com/march-14-2012-webinar-best-practices-r3047284.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Report Now Available: Cambodia Pharmaceuticals &amp; Healthcare Report Q1 2012</title>
	<description>
	
(PR-inside.com) BMI View: Foreign pharmaceutical investors will place Cambodia low on their interest lists as the country is still plagued by corruption and ineffective or outdated regulation. In addition, the government's low healthcare expenditure means funding pressure will continue to hamper the development of pharmaceutical values in the country. We expect investors to increase their interest in this high growth potential market after the administration makes significant changes and improvements to its governance and other healthcare regulatory frameworks.

Headline Expenditure Projections

 * Pharmaceuticals: CHR812.33bn (US$194mn) in 2010 to CHR894.03bn (US$217mn) in 2011; +10.1% in local currency terms and +11.6% in US dollar ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 16:05:50 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-report-now-available-cambodia-r3047221.htm</guid>
	<link>http://reports.pr-inside.com/new-market-report-now-available-cambodia-r3047221.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Market Report, "Malignant Mesothelioma - Pipeline Review, H1 2012", published</title>
	<description>
	
(PR-inside.com) Malignant Mesothelioma - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Malignant Mesothelioma - Pipeline Review, H1 2012', provides an overview of the Malignant Mesothelioma therapeutic pipeline. This report provides information on the therapeutic development for Malignant Mesothelioma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Malignant Mesothelioma. 'Malignant Mesothelioma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:55:46 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-malignant-mesothelioma-r3047201.htm</guid>
	<link>http://reports.pr-inside.com/market-report-malignant-mesothelioma-r3047201.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Recently released market study: Follicular Lymphoma - Pipeline Review, H1 2012</title>
	<description>
	
(PR-inside.com) Follicular Lymphoma - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Follicular Lymphoma - Pipeline Review, H1 2012', provides an overview of the Follicular Lymphoma therapeutic pipeline. This report provides information on the therapeutic development for Follicular Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Follicular Lymphoma. 'Follicular Lymphoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:54:53 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/recently-released-market-study-follicular-r3047200.htm</guid>
	<link>http://reports.pr-inside.com/recently-released-market-study-follicular-r3047200.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Recently released market study: Sleep Disorders - Pipeline Review, H1 2012</title>
	<description>
	
(PR-inside.com) Sleep Disorders - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Sleep Disorders - Pipeline Review, H1 2012', provides an overview of the Sleep Disorders therapeutic pipeline. This report provides information on the therapeutic development for Sleep Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Sleep Disorders. 'Sleep Disorders - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:54:32 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/recently-released-market-study-sleep-r3047198.htm</guid>
	<link>http://reports.pr-inside.com/recently-released-market-study-sleep-r3047198.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Market Report, "Essential Thrombocythemia - Pipeline Review, H1 2012", published</title>
	<description>
	
(PR-inside.com) Essential Thrombocythemia - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Essential Thrombocythemia - Pipeline Review, H1 2012', provides an overview of the Essential Thrombocythemia therapeutic pipeline. This report provides information on the therapeutic development for Essential Thrombocythemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Essential Thrombocythemia. 'Essential Thrombocythemia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:54:22 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-essential-thrombocythemia-r3047197.htm</guid>
	<link>http://reports.pr-inside.com/market-report-essential-thrombocythemia-r3047197.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>"AIDS Associated Dementia - Pipeline Review, H1 2012" now available at Fast Market Research</title>
	<description>
	
(PR-inside.com) AIDS Associated Dementia - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'AIDS Associated Dementia - Pipeline Review, H1 2012', provides an overview of the AIDS Associated Dementia therapeutic pipeline. This report provides information on the therapeutic development for AIDS Associated Dementia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for AIDS Associated Dementia. 'AIDS Associated Dementia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:54:23 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/aids-associated-dementia-pipeline-review-r3047196.htm</guid>
	<link>http://reports.pr-inside.com/aids-associated-dementia-pipeline-review-r3047196.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Market Report, "Open-Angle Glaucoma - Pipeline Review, H1 2012", published</title>
	<description>
	
(PR-inside.com) Open-Angle Glaucoma - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Open-Angle Glaucoma - Pipeline Review, H1 2012', provides an overview of the Open-Angle Glaucoma therapeutic pipeline. This report provides information on the therapeutic development for Open-Angle Glaucoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Open-Angle Glaucoma. 'Open-Angle Glaucoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:53:08 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-open-angle-glaucoma-r3047195.htm</guid>
	<link>http://reports.pr-inside.com/market-report-open-angle-glaucoma-r3047195.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Myocardial Ischemia - Pipeline Review, H1 2012</title>
	<description>
	
(PR-inside.com) Myocardial Ischemia - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Myocardial Ischemia - Pipeline Review, H1 2012', provides an overview of the Myocardial Ischemia therapeutic pipeline. This report provides information on the therapeutic development for Myocardial Ischemia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Myocardial Ischemia. 'Myocardial Ischemia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:50:01 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-myocardial-ischemia-r3047184.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-myocardial-ischemia-r3047184.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Spinal Cord Injury - Pipeline Review, H1 2012</title>
	<description>
	
(PR-inside.com) Spinal Cord Injury - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Spinal Cord Injury - Pipeline Review, H1 2012', provides an overview of the Spinal Cord Injury therapeutic pipeline. This report provides information on the therapeutic development for Spinal Cord Injury, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Spinal Cord Injury. 'Spinal Cord Injury - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:49:24 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-spinal-cord-r3047181.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-spinal-cord-r3047181.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>"Liver Failure - Pipeline Review, H1 2012" is now available at Fast Market Research</title>
	<description>
	
(PR-inside.com) Liver Failure - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Liver Failure - Pipeline Review, H1 2012', provides an overview of the Liver Failure therapeutic pipeline. This report provides information on the therapeutic development for Liver Failure, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Liver Failure. 'Liver Failure - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:48:59 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/liver-failure-pipeline-review-h-r3047180.htm</guid>
	<link>http://reports.pr-inside.com/liver-failure-pipeline-review-h-r3047180.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>New Market Research Report: Tardive Dyskinesia - Pipeline Review, H1 2012</title>
	<description>
	
(PR-inside.com) Tardive Dyskinesia - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Tardive Dyskinesia - Pipeline Review, H1 2012', provides an overview of the Tardive Dyskinesia therapeutic pipeline. This report provides information on the therapeutic development for Tardive Dyskinesia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Tardive Dyskinesia. 'Tardive Dyskinesia - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:48:26 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/new-market-research-report-tardive-dyskinesia-r3047179.htm</guid>
	<link>http://reports.pr-inside.com/new-market-research-report-tardive-dyskinesia-r3047179.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Market Report, "Parkinson's Disease - Pipeline Review, H1 2012", published</title>
	<description>
	
(PR-inside.com) Parkinson's Disease - Pipeline Review, H1 2012

Summary

Global Markets Direct's, 'Parkinson's Disease - Pipeline Review, H1 2012', provides an overview of the Parkinson's Disease therapeutic pipeline. This report provides information on the therapeutic development for Parkinson's Disease, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Parkinson's Disease. 'Parkinson's Disease - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 15:48:10 GMT</pubDate>
        
	<guid>http://reports.pr-inside.com/market-report-parkinson-s-disease-r3047178.htm</guid>
	<link>http://reports.pr-inside.com/market-report-parkinson-s-disease-r3047178.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Healed of cancer – thanks to a Mammogram</title>
	<description>
	
(PR-inside.com) Avril was diagnosed with breast cancer in March 2011. After a mammogram she was called back to receive the devastating news that she had breast cancer. She felt well, had no symptoms, had never smoked, ate a healthy diet and exercised regularly, so how could this be? There was no explanation, it can happen to anyone! 
Before she knew it, she had surgery to remove the lump followed by radiotherapy. Thanks to the advanced technology of a mammogram, her tumour was caught in the very early stages. She counts herself very lucky indeed. 2011 was a very difficult year for ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 13:50:08 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/healed-of-cancer-thanks-to-r3046900.htm</guid>
	<link>http://www.pr-inside.com/healed-of-cancer-thanks-to-r3046900.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Ovarian Cancer: New Tumour Suppressor Gene Identified</title>
	<description>
	
(PR-inside.com) The hVps37A gene as such is not unknown to scientists. In the period 2004 to 2007, a systematic genome search as part of a project funded by the Austrian Science Fund FWF determined that, among others, this gene is down-regulated in ovarian cancer. The then head of studies, Prof. Michael Krainer, has now studied the function of this gene further in this particular type of cancer. The published results of this follow-up project show that hVps37A is a hitherto unknown tumour suppressor gene.

Receptor for Success
With reference to the study, Prof. Krainer, Director of the Molecular Genetics Working Group, Department of ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 12:35:14 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/ovarian-cancer-new-tumour-suppressor-gene-r3046688.htm</guid>
	<link>http://www.pr-inside.com/ovarian-cancer-new-tumour-suppressor-gene-r3046688.htm</link>
</item>
	<item>
	<category>Health</category>
	<title>Emerald to publish new editions of seminal audiology textbooks</title>
	<description>
	
(PR-inside.com) United Kingdom, February 2012 – Emerald Group Publishing Limited is pleased to announce that it will publish new editions of the bestselling and seminal textbooks An Introduction to the Psychology of Hearing, which is available now, and An Introduction to the Physiology of Hearing to be published in August 2012.

As the leading textbook in the field of auditory perception, An Introduction to the Psychology of Hearing was first published in 1977 and has become an important source of information used by active researchers in the field. The newly revised 6th edition will again be authored by Brian Moore of the ..
	</description>
	
	<pubDate>Mon, 13 Feb 2012 10:20:32 GMT</pubDate>
        
	<guid>http://www.pr-inside.com/emerald-to-publish-new-editions-of-r3046456.htm</guid>
	<link>http://www.pr-inside.com/emerald-to-publish-new-editions-of-r3046456.htm</link>
</item>
</channel>
</rss>
